Understanding the upper bound of survival for conducting and critically appraising economic evaluations of low-risk cancers

Understanding the upper bound of survival for low-risk cancers enables health economists to more accurately conduct cost-effectiveness analyses and assess the credibility of published economic evaluations. [Figure: see text].

Authors

Myra Wang
Ishita Joshi
Xuanqian Xie (ORCID: https://orcid.org/0000-0002-4331-8233)
Chunmei Li (ORCID: https://orcid.org/0000-0002-7501-1674)

Publication Details

Journal: Expert Review of Pharmacoeconomics & Outcomes Research
Published: 2025-06-18
DOI: https://doi.org/10.1080/14737167.2025.2522326
Citations: 1
Primary Topic: Health Systems, Economic Evaluations, Quality of Life
Type: article
Field-Weighted Citation Impact: 3.13

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Understanding the upper bound of survival for conducting and critically appraising economic evaluations of low-risk cancers

Myra Wang, Ishita Joshi, Xuanqian Xie, Chunmei Li

Jun 18, 2025

1 citations

Expert Review of Pharmacoeconomics & Outcomes Research

Health Systems, Economic Evaluations, Quality of Life

3.13

article

Understanding the upper bound of survival for conducting and critically appraising economic evaluations of low-risk cancers

Myra Wang, Ishita Joshi, Xuanqian Xie, Chunmei Li

June 18, 2025article en

1 citations

Abstract

Expert Review of Pharmacoeconomics & Outcomes ResearchVol. 25(7)

Openalex Percentile: Top 8%

Health Systems, Economic Evaluations, Quality of Life

3.13

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Understanding the upper bound of survival for conducting and critically appraising economic evaluations of low-risk cancers — Myra Wang, Ishita Joshi, et al. · Expert Review of Pharmacoeconomics & Outcomes Research (2025) | TGRS Research Map | TGRS